News | Cardiovascular Ultrasound | June 15, 2017

CPAP Therapy Improves Heart Function in Patients With Severe Obstructive Sleep Apnea

cardiac ultrasound echo used to assess CPAP patient cardiac improvement

June 15, 2017 – Obstructive sleep apnea (OSA) is a common sleep disorder affecting millions of people, roughly 4 percent of men and 2 percent of women. This disorder, in which a person stops breathing periodically during sleep, is also associated with left ventricular (LV) diastolic dysfunction. Researchers recently found a new therapy that shows promise to lessen the symptoms of this debilitating condition. 

Researchers explored the effects of continuous positive airway pressure (CPAP) therapy on the underlying mechanisms involving LV diastolic dysfunction. The comprehensive assessment was conducted using diastolic stress echocardiography and two dimensional (2-D) speckle tracking analysis. It demonstrated improved left ventricular diastolic function, as well as improvements in left and right ventricular strain parameters. “CPAP therapy significantly improves LV diastolic function in patients with severe OSA patients” said Darae Kim, M.D.
 
Researchers on the study, “Effect of Continuous Positive Airway Pressure Therapy on Left Ventricular Diastolic Function in Patients with Severe Obstructive Sleep Apnea (CPAP-OASIS) assessed by Tissue Doppler, 2D Speckle Tracking and Exercise Hemodynamics: A Randomized Sham Controlled Clinical Trial,” included Darae Kim, Chi Young Shim, Sungha Park, Jong-Won Ha, Geu-Ru Hong, and Namsik Chung of Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea; and Yang-Je Cho of Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
 
Kim presented a poster based on this research during the Arthur E. Weyman Young Investigator’s Award Competition at the recent 2017 meeting of the American Society of Echocardiography (ASE).

 

Related Content of Sleep Apnea and the Heart

Study Suggests Ways to Block Hypertension in Sleep Apnea Patients

Implantable Device Improved Central Sleep Apnea, Reduces Heart Failure Complications

Statins May Lower Heart Disease Risk in People with Sleep Apnea

 

For more information: ASEcho.org


Related Content

News | ASE

June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help ...

Home June 12, 2024
Home
Feature | ASE | Christine Book

June 4, 2024 — The countdown has begun ahead of the American Society of Echocardiography 35th Annual ASE Scientific ...

Home June 04, 2024
Home
News | ASE

July 5, 2023 — Research presented during the American Society of Echocardiography’s 34th Annual Scientific Sessions, ASE ...

Home July 05, 2023
Home
News | ASE

June 29, 2023 — At the conclusion of the American Society of Echocardiography 2023 Scientific Sessions, ASE 2023, the ...

Home June 29, 2023
Home
News | ASE

June 29, 2023 — A large, multi-center study presented during the American Society of Echocardiography’s (ASE) 34th ...

Home June 29, 2023
Home
Feature | ASE | Christine Book

June 27, 2023 — The 2023 American Society of Echocardiography Scientific Sessions, ASE 2023, “Foundations and the future ...

Home June 27, 2023
Home
News | ASE

June 23, 2023 — Building on its established leadership in cardiovascular ultrasound, Philips will showcase its ...

Home June 23, 2023
Home
News | ASE

June 13, 2023 — Core Sound Imaging, Inc. has announced the introduction of the Studycast Integration Program. The ...

Home June 13, 2023
Home
News | ASE
May 5, 2022 – The American Society of Echocardiography (ASE), the largest global organization for cardiovascular ...
Home May 05, 2022
Home
News | ASE
April 21, 2022 – The American Society of Echocardiography (ASE) is pleased to announce that its membership has elected ...
Home April 21, 2022
Home
Subscribe Now